Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000244110

Medchemexpress LLC (+)-(R)-[(E)-3-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)acryloyl]-2-piperidineethanol | 121524-18-3 | 99.2% | 375.46 | C23H25N3O2 | 50 MG
SDP

Catalog No. 5000244110
Encompass_Preferred

FK 453 is a non-xanthine adenosine A1 receptor antagonist (compound 1d) used in pharmacological research. It is reported as potent and selective, with an IC50 of 17.2 nM. The compound has chemical formula C23H25N3O2, molecular weight 375.46, and reported purity 99.20%.

  • Potent and selective A1 receptor antagonist (IC50 17.2 nM).
  • High reported purity suitable for research use (99.2%).
  • Chemical formula C23H25N3O2 and molecular weight 375.46.
  • Available in small research quantities, for example 50 mg.
  • Supplied with supporting analytical data such as COA, HPLC, and LCMS.

Catalog No. 50-002-44110 Supplier Medchemexpress LLC Supplier No. HY105275A50MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

FK 453 is a non-xanthine adenosine A1 receptor antagonist (compound 1d) used in pharmacological research. It is reported as potent and selective, with an IC50 of 17.2 nM. The compound has chemical formula C23H25N3O2, molecular weight 375.46, and reported purity 99.20%.

  • Potent and selective A1 receptor antagonist (IC50 17.2 nM).
  • High reported purity suitable for research use (99.2%).
  • Chemical formula C23H25N3O2 and molecular weight 375.46.
  • Available in small research quantities, for example 50 mg.
  • Supplied with supporting analytical data such as COA, HPLC, and LCMS.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.